Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Uppsala Pharma AB
AB
Active
Org 5568304652
Södra Rudbecksgatan 4
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2010
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 0
EBITDA margin
—
+5% vs 2024
Equity ratio
84.0%
Financial strength
Net profit 2025
SEK 60K
-44% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 0
—
EBITDA
SEK -7K
+5%
Net profit
SEK 60K
-44%
Total assets
SEK 4,1M
+2%
Equity
SEK 3,4M
-4%
Employees
0
—
Company information
Legal name
Uppsala Pharma AB
Org number
5568304652
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8 december 2010
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolagets huvudinriktning skall vara att bedriva medicinsk forskning och utveckling samt försäljning av medicinska preparat.
Contact
Address
Södra Rudbecksgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−13
−7
−7
−8
−7
Depreciation & amort.
−0
—
—
—
—
EBIT
−13
−7
−7
−8
−7
Net financials
−16
16
111
143
82
Profit before tax
2
9
104
135
75
Tax
−0
—
−14
−28
−15
Net profit
2
9
90
107
60
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
4 339
4 348
3 868
4 003
4 064
Equity
3 943
3 764
3 659
3 562
3 413
Long-term debt
396
583
196
400
609
Short-term debt
0
—
14
42
43
Total debt
396
583
210
441
651
Financial ratios
5-year trend
EBITDA margin
-731200.0%
This company
15.8%
Market median
-4627948% vs market
2021
2025
Equity ratio
84.0%
This company
38.2%
Market median
+120% vs market
2021
2025
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
2021
2025
Net profit margin
5977200.0%
This company
8.1%
Market median
+73792493% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
BT
Bo Tom Georg Saldeen
Deputy Board Member
2022
Former (1)
TG
Tom Gustaf Per Saldeen
Board of Directors
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Uppsala Pharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Tom Gustaf Per Saldeen
Board of Directors
0 companies
Bo Tom Georg Saldeen
Deputy Board Member
0 companies